Arama

EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

PDF

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 6 results

Ranking

Release Date Sort Sort Article Type

Prevalence of Celiac disease in Turkish children with type 1 Diabetes Mellitus and their non-diabetic first-degree relatives

Sinan SARI, Ediz YEŞİLKAYA, Ödül EĞRİTAŞ, Aysun BİDECİ, Peyami CİNAZ, Buket DALGIÇ

(Turk J Gastroenterol 2010; 21: 34-38) DOI: 10.4318/tjg.2010.0045

Abstract Full Text ( PDF) Related Articles

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Gökhan KABAÇAM, Murat TÖRÜNER

(Turk J Gastroenterol 2010; 21: 107-112) DOI: 10.4318/tjg.2010.0066

Abstract Full Text ( PDF) Related Articles

Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection

Süleyman Sayar, Kemal Kürbüz, Resul Kahraman, Oğuzhan Öztürk, Zuhal Çalışkan, Hamdi Levent Doğanay, Kamil Özdil

(Turk J Gastroenterol 2020; 31: 522-528) DOI: 10.5152/tjg.2020.19295

Abstract Full Text ( PDF) Related Articles

Prevalence of Celiac disease in Turkish children with type 1 Diabetes Mellitus and their non-diabetic first-degree relatives

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection

Treatment Adherence of Anti-TNF Drugs in the Patients with Inflammatory Bowel Disease: A Scale Development Study

Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn’s Disease in Routine Clinical Practice in Turkey

Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B